Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Dexcom (DXCM) Accumulated Depreciation & Amortization (2016 - 2026)

Dexcom has reported Accumulated Depreciation & Amortization over the past 17 years, most recently at $11.7 million for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 27.17% to $11.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.7 million through Mar 2026, up 27.17% year-over-year, with the annual reading at $39.5 million for FY2025, 1.0% down from the prior year.
  • Accumulated Depreciation & Amortization was $11.7 million for Q1 2026 at Dexcom, down from $39.5 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $466.3 million in Q3 2023 and troughed at $9.2 million in Q1 2025.
  • The 5-year median for Accumulated Depreciation & Amortization is $39.5 million (2025), against an average of $84.8 million.
  • Year-over-year, Accumulated Depreciation & Amortization skyrocketed 432.71% in 2023 and then plummeted 97.81% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $46.7 million in 2022, then decreased by 10.28% to $41.9 million in 2023, then fell by 4.77% to $39.9 million in 2024, then dropped by 1.0% to $39.5 million in 2025, then crashed by 70.38% to $11.7 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Accumulated Depreciation & Amortization are $11.7 million (Q1 2026), $39.5 million (Q4 2025), and $9.6 million (Q3 2025).